
Giredestrant-Everolimus Doubles Survival in ESR1-Mutated Breast Cancer
The evERA trial shows the all-oral combination of giredestrant and everolimus significantly improves progression-free survival for patients with advanced breast cancer.
Cycle on Cycle and Care: How the menstrual cycle works, heavy, painful, irregular, PMS and PMDD and Cycle tracking and apps.

The evERA trial shows the all-oral combination of giredestrant and everolimus significantly improves progression-free survival for patients with advanced breast cancer.

A new NHS genomic test can diagnose brain tumour type in under two hours during surgery, replacing waits of up to eight weeks.

Health and fitness experts caution that popular social media advice to tailor exercise to menstrual cycle phases lacks strong scientific backing.

A uterus-preserving laparoscopic procedure combining peritoneal pull-down neovaginoplasty with catheter-guided uterovaginal anastomosis restored menstrual function.

A survey by the Alzheimer's Society reveals hundreds of families wait months or years for a dementia diagnosis.

A large study found embryos with whole chromosome abnormalities resulted in zero live births.

A 43-year-old woman with a high breast cancer risk was billed $1,191.10 for a preventive MRI, despite pre-approval.

Abortion providers report more later-term procedures as state bans spread and insurance access declines, creating major financial and logistical barriers.
NHS England will offer at-home HPV self-collection kits to 4 million women aged 30-65 who have missed NHS cervical screening appointments, aiming to boost participation and move toward eliminating cervical cancer by 2040.

GLP-1 drugs show promise in treating polyendocrine metabolic ovarian syndrome.

A new study finds that women living in more disadvantaged neighborhoods experience higher rates of menstrual disturbances, particularly dysmenorrhea, even after accounting for individual socioeconomic factors.